Company Overview
Snapshot
Founded in October 2021 by Avi Motova and Dr shlomi isrelit, CatAI operates with 1–10 employees. The company focuses on AI-enhanced personal health care monitoring, holding a patent in this domain.
Business overview
CatAI develops an AI-enhanced remote patient monitoring solution designed for hospitals, clinics, nursing homes, and assisted living facilities, offered as a SaaS-based platform. Its core technology captures vital signs through devices like tablets or smartphones, processing data for healthcare providers to enable continuous monitoring and rapid response. Additionally, CatAI offers ORALYZE, a system that utilizes mobile phone imaging for the early detection of oral cancer with high accuracy. The company operates within the Health Tech & Life Sciences sector, specifically in Digital Healthcare and Patient Remote Monitoring, leveraging Artificial Intelligence and Machine Learning.
Log in to access full profile ›Company Intelligence Q&A
- What is CatAI's primary offering for healthcare providers?
- CatAI provides a remote patient monitoring (RPM) solution that allows hospitals, home care companies, and elderly care facilities to track medical parameters. The AI platform captures vital signs via mobile devices and sends data to healthcare providers' dashboards for continuous monitoring.
- What is the ORALYZE system?
- ORALYZE is CatAI's system for the early detection of oral cancer, utilizing mobile phone imaging. Research on this system, conducted in collaboration with the North of Israel Hospital, the Israeli Ministry of Health, and IBM, was published in the journal Cancers.
- What is CatAI's business model?
- CatAI employs B2G, B2B2C, and B2B business models, targeting government entities, businesses, and consumers through partnerships.
- When was CatAI founded?
- CatAI was founded in October 2021.
- Who are the founders of CatAI?
- CatAI was founded by Avi Motova and Dr shlomi isrelit.